• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成内源性抑制剂的最新进展。

Update on endogenous inhibitors of angiogenesis.

作者信息

Sato Yasufumi

机构信息

Department of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan.

出版信息

Endothelium. 2006 Mar-Apr;13(2):147-55. doi: 10.1080/1062332060069110.

DOI:10.1080/1062332060069110
PMID:16728331
Abstract

Angiogenesis is regulated by a local balance between the levels of endogenous stimulators and inhibitors of angiogenesis. Understanding of the mechanism of angiogenesis has advanced significantly since the discovery of two members of the family of angiogenesis stimulators, i.e., vascular endothelial growth factor family proteins and angiopoietins. These factors act on endothelial cells to stimulate angiogenesis. In contrast, most of angiogenesis inhibitors do not seem to have such characteristics. Very few genes encoding molecules that selectively inhibit angiogenesis have been discovered. This review will focus on our current understanding of endogenous inhibitors of angiogenesis.

摘要

血管生成受血管生成内源性刺激因子和抑制因子水平之间的局部平衡调节。自血管生成刺激因子家族的两个成员,即血管内皮生长因子家族蛋白和血管生成素被发现以来,对血管生成机制的理解有了显著进展。这些因子作用于内皮细胞以刺激血管生成。相比之下,大多数血管生成抑制剂似乎没有这样的特性。目前仅发现了极少数编码选择性抑制血管生成分子的基因。本综述将聚焦于我们目前对血管生成内源性抑制剂的理解。

相似文献

1
Update on endogenous inhibitors of angiogenesis.血管生成内源性抑制剂的最新进展。
Endothelium. 2006 Mar-Apr;13(2):147-55. doi: 10.1080/1062332060069110.
2
Endogenous inhibitors of angiogenesis.血管生成的内源性抑制剂
Cancer Res. 2005 May 15;65(10):3967-79. doi: 10.1158/0008-5472.CAN-04-2427.
3
Understanding the biology of angiogenesis: review of the most important molecular mechanisms.了解血管生成生物学:重要分子机制综述
Blood Cells Mol Dis. 2007 Sep-Oct;39(2):212-20. doi: 10.1016/j.bcmd.2007.04.001. Epub 2007 Jun 6.
4
Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey.细胞外血管生成生长因子相互作用:血管生成相互作用组研究
Endothelium. 2006 Mar-Apr;13(2):93-111. doi: 10.1080/10623320600698011.
5
The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells.血管抑制素家族:一种在内皮细胞中进行基因编程的血管生成负调控系统。
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):37-41. doi: 10.1161/01.ATV.0000252062.48280.61. Epub 2006 Nov 9.
6
Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.抗血管生成化合物对骨骺生长板影响的综述。
Toxicol Pathol. 2006;34(2):131-47. doi: 10.1080/01926230600611836.
7
The vasohibin family: Novel regulators of angiogenesis.血管抑素家族:新型血管生成调节剂。
Vascul Pharmacol. 2012 May-Jun;56(5-6):262-6. doi: 10.1016/j.vph.2012.01.002. Epub 2012 Jan 21.
8
Pericellular proteases in angiogenesis and vasculogenesis.血管生成和血管发生中的细胞周围蛋白酶
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):716-28. doi: 10.1161/01.ATV.0000209518.58252.17. Epub 2006 Feb 9.
9
Structural basis for the functions of endogenous angiogenesis inhibitors.内源性血管生成抑制剂功能的结构基础。
Cold Spring Harb Symp Quant Biol. 2005;70:399-410. doi: 10.1101/sqb.2005.70.017.
10
Angiogenesis--an update.血管生成——最新进展
Pediatr Endocrinol Rev. 2005 Mar;2(3):391-8.

引用本文的文献

1
Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery.草药在五大癌症抗转移治疗方法上的最新进展:从传统医学到现代药物研发
Antioxidants (Basel). 2021 Mar 27;10(4):527. doi: 10.3390/antiox10040527.
2
High preoperative plasma vasohibin-1 concentration predicts better prognosis in patients with non-small cell lung carcinoma.术前血浆血管抑制素-1浓度高预示非小细胞肺癌患者预后较好。
Health Sci Rep. 2018 May 17;1(6):e40. doi: 10.1002/hsr2.40. eCollection 2018 Jun.
3
The expression of vasohibin-1 and its prognostic significance in bladder cancer.
血管抑制素-1在膀胱癌中的表达及其预后意义
Exp Ther Med. 2017 Oct;14(4):3477-3484. doi: 10.3892/etm.2017.4969. Epub 2017 Aug 18.
4
The Vasohibin Family.血管抑制素家族
Pharmaceuticals (Basel). 2010 Feb 5;3(2):433-440. doi: 10.3390/ph3020433.
5
Vasohibin-1 expression is regulated by transforming growth factor-β/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells.血管抑肽-1 的表达受肿瘤相关巨噬细胞和胰腺癌细胞间转化生长因子-β/骨形态发生蛋白信号通路的调控。
J Interferon Cytokine Res. 2013 Aug;33(8):428-33. doi: 10.1089/jir.2012.0046. Epub 2013 May 7.
6
The vasohibin family: a novel family for angiogenesis regulation.血管生成素家族:调控血管生成的新家族。
J Biochem. 2013 Jan;153(1):5-11. doi: 10.1093/jb/mvs128. Epub 2012 Oct 25.
7
A microarray analysis of angiogenesis modulation effect of Xuefu Zhuyu Decoction on endothelial cells.雪府逐瘀汤对血管生成调控作用的基因芯片分析。
Chin J Integr Med. 2012 Jul;18(7):502-6. doi: 10.1007/s11655-012-1143-6. Epub 2012 Jul 7.
8
Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast.血管抑素-1 作为乳腺导管原位癌侵袭性行为的潜在预测因子。
Cancer Sci. 2010 Apr;101(4):1051-8. doi: 10.1111/j.1349-7006.2009.01483.x.
9
Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis.内源性血管生成抑制剂 vasohibin1 具有广谱抗淋巴管生成活性,并抑制淋巴结转移。
Am J Pathol. 2010 Apr;176(4):1950-8. doi: 10.2353/ajpath.2010.090829. Epub 2010 Feb 4.
10
Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice.伊司替宁是一种新型分泌型血管生成抑制剂,可抑制小鼠肿瘤生长。
J Cell Mol Med. 2011 Feb;15(2):359-74. doi: 10.1111/j.1582-4934.2009.00961.x.